期刊文献+

经食道超声对射频消融术前房颤患者左房及左心耳血栓的诊断价值 被引量:7

下载PDF
导出
摘要 目的探讨经食道超声对射频消融术前心房颤动(房颤)患者左房及左心耳血栓的诊断价值。方法 105例行射频消融术治疗的房颤患者,术前均进行经食道超声和经胸超声检测,对比两种检测方法对左房及左心耳血栓的检测效果。结果经食道超声检测出左房血栓24例(22.9%)、左心耳血栓22例(21.0%),经胸部超声分别为8例(7.6%)、7例(6.7%),经食道超声血栓检出率均高于经胸部超声,差异具有统计学意义(P<0.05)。经食道超声检测出左房自发性显像19例(18.1%)、左心耳自发性显像11例(10.5%),经胸部超声分别为2例(1.9%)、0例(0),经食道超声自发性显像检出率均高于经胸部超声,差异具有统计学意义(P<0.05)。结论经食道超声检测左房及左心耳血栓检出率高,可在房颤患者射频消融术前推广运用。
作者 汤颖
出处 《中国实用医药》 2016年第28期72-73,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献49

  • 1European Heart Rhythm Association: European Asso- ciation for Cardio-Thoracic Surgery Camm A J, Kirch- hof P,Lip G Y,Schotten U,Savelieva I,Ernst S,et al. Guidelines for the Management of Atrial Fibrillation: The Task Force for the Management of Atrial Fibrilla- tion of the European Society of Cardiology (ESC)[J]. Eur Heart J,2010,31:2369-2429.
  • 2Musial J, Brzezinska-Kolarz B, Z61cinski M, Lelakowski J,Szczeklik A. Ex vivo thrombin generation in patients with venous thromhoembolie disease or atrial fibrilla- tion on long-term oral anticoagulation[J]. Clin Appl Thromb Hemost, 2010,16 : 614-621.
  • 3Pan M,Zhu J H,Jiang W P,Liu Z H,Li H M,Yu X H,et al. Inflammation:a possible pathogenic link to atrial fibril- lation[J]. Med Hypotheses, 2006,67 : 1305-1307.
  • 4Stollberger C,Chnupa P, Kronik G, Brainin M, Finster- er J, Schneider B, et al. Transesophageal echocardio- graphy to assess embolic risk in patients with atrial fi- brillation. ELAT Study Group. Embolism in Left AtrialThrombi[J]. Ann Intern Med,1998,128630-638.
  • 5Sorescu D, Turk R J,Cain M, Lerakis S. Clinical and tran- sthoracic echocardiographic predictors of abnormal transesophageal findings in patients with suspected cardiac source of embolism[J]. Am J Med Sci, 2003,326 : 31-34.
  • 6Fuster V, Ryd6n L E, Cannom D S, Crijns H J, Curtis A B,Ellenbogen K A,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text:a report of the American College of Cardiology/A- merican Heart Association Task Force on practice guide- lines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J]. Europace, 2006,8 : 651-745.
  • 7Cairns J A, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Commit- tee. Canadian Cardiovascular Society Atrial Fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter[J]. Can J Cardiol,2011,27:74-90.
  • 8You J J, Singer D E, Howard P A, Lane D A, Eckrnan M H, Fang M C, et al. Antithrombotic therapy for atrial fibrillation:Antithrombotie Therapy and Prevention of Thrombosis,gth Ed: American College of Chest Physi- cians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012,141 (2 Suppl) : e531S-e575S.
  • 9Berisha B, Gashi M, Krasniqi X, Pllana E, Koeinaj D. Limitations of CHADS2 scoring system in predicting stroke risk-need to change the age criteria[J]. Med Arh,2011,65:27-29.
  • 10Baruch L, Gage B F, Horrow J, Juul-Moller S, Labovitz A,Persson M, et al. Can patients at elevated risk of stroke treated with anticoagulants be further risk strat- ified?[J]. Stroke, 2007,38 : 2459-2463.

共引文献14

同被引文献29

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部